Reaction Details Report a problem with these data
Target
Arginase-1
Ligand
BDBM290386
Substrate
n/a
Meas. Tech.
Inhibition of Arginase
IC50
625±n/a nM
Citation
 Van Zandt, M; Jagdmann, GE Arginase inhibitors as therapeutics US Patent  US11389464 Publication Date 7/19/2022 
Target
Name:
Arginase-1
Synonyms:
ARG1 | ARGI1_HUMAN | Liver-type arginase | Type I arginase
Type:
PROTEIN
Mol. Mass.:
34737.53
Organism:
Homo sapiens (Human)
Description:
ChEMBL_978893
Residue:
322
Sequence:
MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK
  
Inhibitor
Name:
BDBM290386
Synonyms:
(3R,4S)-3-amino-4-(3-boronopropyl)-1-(3-(4- chlorophenyl)propyl)pyrrolidine-3-carboxylic acid | US10098902, Example 22 | US10603330, Example 22 | US11389464, Example 22
Type:
Small organic molecule
Emp. Form.:
C17H26BClN2O4
Mol. Mass.:
368.663
SMILES:
N[C@]1(CN(CCCc2ccc(Cl)cc2)C[C@@H]1CCCB(O)O)C(O)=O |r|
Structure:
Search PDB for entries with ligand similarity: